Drugs that contain Dexamethasone

1. Drug name - DEXTENZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9254267 OCULAR THERAPEUTIX Composite hydrogel drug delivery systems Sep, 2024

(1 year, 11 months from now)

US8563027 OCULAR THERAPEUTIX Drug delivery through hydrogel plugs Feb, 2030

(7 years from now)

US8409606 OCULAR THERAPEUTIX Drug delivery through hydrogel plugs May, 2030

(7 years from now)

Treatment: Dextenza is approved for the treatment of ocular pain following ophthalmic surgery

Dosage: INSERT;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.4MG INSERT;OPHTHALMIC Prescription

2. Drug name - DEXYCU KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6960346 EYEPOINT PHARMS Vehicles for delivery of biologically active substances Jul, 2023

(8 months from now)

US10799642 EYEPOINT PHARMS Dose guides for injection syringe May, 2032

(9 years from now)

US10028965 EYEPOINT PHARMS Use of sustained release dexamethasone in post-cataract surgery inflammation May, 2034

(11 years from now)

US10159683 EYEPOINT PHARMS Use of sustained release dexamethasone in post-cataract surgery inflammation May, 2034

(11 years from now)

US10022502 EYEPOINT PHARMS Dose guides for injection syringe Jun, 2034

(11 years from now)

Treatment: Treatment of postoperative inflammation

Dosage: SUSPENSION;INTRAOCULAR

More Information on Dosage
Strength Dosage Availability
9% SUSPENSION;INTRAOCULAR Prescription

3. Drug name - HEMADY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10537585 DEXCEL PHARMA Compositions comprising dexamethasone Dec, 2037

(15 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
20MG TABLET;ORAL Prescription

4. Drug name - OZURDEX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8506987 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US10702539 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US9192511 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US10076526 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US8034370 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US8034366 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US6899717 ALLERGAN Methods and apparatus for delivery of ocular implants Nov, 2023

(1 year, 28 days from now)

Treatment: Treatment of macular edema; treatment of uveitis; Treatment of diabetic macular edema; treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo); treatment of non-infectious uveitis affecting the posterior segment of the eye; Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex

Dosage: IMPLANT;INTRAVITREAL

More Information on Dosage
Strength Dosage Availability
0.7MG IMPLANT;INTRAVITREAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.